158 related articles for article (PubMed ID: 19138962)
1. Cancer prevention: epigenetics steps up to the plate.
Issa JP
Cancer Prev Res (Phila); 2008 Sep; 1(4):219-22. PubMed ID: 19138962
[No Abstract] [Full Text] [Related]
2. Epigenetic Modulators and the New Immunotherapies.
Dear AE
N Engl J Med; 2016 Feb; 374(7):684-6. PubMed ID: 26886527
[No Abstract] [Full Text] [Related]
3. DNA methylation: its role in cancer development and therapy.
Kurkjian C; Kummar S; Murgo AJ
Curr Probl Cancer; 2008; 32(5):187-235. PubMed ID: 18926282
[No Abstract] [Full Text] [Related]
4. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
Cowan LA; Talwar S; Yang AS
Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
[TBL] [Abstract][Full Text] [Related]
5. Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?
Lowder JN; Taverna P; Issa JP
Epigenomics; 2015 Oct; 7(7):1083-8. PubMed ID: 26541345
[No Abstract] [Full Text] [Related]
6. Targeting the epigenome for the treatment of thoracic malignancies.
Schrump DS; Nguyen DM
Thorac Surg Clin; 2006 Nov; 16(4):367-77, vi. PubMed ID: 17240824
[TBL] [Abstract][Full Text] [Related]
7. Making bad cells go good: the promise of epigenetic therapy.
Sausville EA; Carducci MA
J Clin Oncol; 2005 Jun; 23(17):3875-6. PubMed ID: 15946932
[No Abstract] [Full Text] [Related]
8. Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy.
Marquez VE; Kelley JA; Agbaria R; Ben-Kasus T; Cheng JC; Yoo CB; Jones PA
Ann N Y Acad Sci; 2005 Nov; 1058():246-54. PubMed ID: 16394141
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic therapies move into new territory, but how exactly do they work?
Tuma RS
J Natl Cancer Inst; 2009 Oct; 101(19):1300-1. PubMed ID: 19755677
[No Abstract] [Full Text] [Related]
10. DNA hypomethylation therapies and hemoglobin disorders. [An interview with Hassana Fathallah by H&O].
Fathallah H
Clin Adv Hematol Oncol; 2008 Nov; 6(11):806-8. PubMed ID: 19194363
[No Abstract] [Full Text] [Related]
11. DNA methyltransferase inhibitors for cancer therapy.
Brueckner B; Kuck D; Lyko F
Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
[TBL] [Abstract][Full Text] [Related]
12. The p53 protein plays a central role in the mechanism of action of epigentic drugs that alter the methylation of cytosine residues in DNA.
Levine AJ
Oncotarget; 2017 Jan; 8(5):7228-7230. PubMed ID: 28129641
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and cancer.
Kulis M; Esteller M
Adv Genet; 2010; 70():27-56. PubMed ID: 20920744
[TBL] [Abstract][Full Text] [Related]
14. Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.
Stresemann C; Lyko F
Int J Cancer; 2008 Jul; 123(1):8-13. PubMed ID: 18425818
[TBL] [Abstract][Full Text] [Related]
15. Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes.
Steensma DP; Stone RM
Hematol Oncol Clin North Am; 2010 Apr; 24(2):389-406. PubMed ID: 20359633
[TBL] [Abstract][Full Text] [Related]
16. Silencing the critics: new studies move closer to answering epigenetic questions.
Tuma RS
J Natl Cancer Inst; 2004 Nov; 96(22):1652-3. PubMed ID: 15547174
[No Abstract] [Full Text] [Related]
17. Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).
Momparler RL
Semin Oncol; 2005 Oct; 32(5):443-51. PubMed ID: 16210084
[TBL] [Abstract][Full Text] [Related]
18. Histone lysine methylation: an epigenetic modification?
Blackledge NP; Klose RJ
Epigenomics; 2010 Feb; 2(1):151-61. PubMed ID: 22122751
[TBL] [Abstract][Full Text] [Related]
19. [Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].
Daskalakis M; Blagitko-Dorfs N; Hackanson B; Lübbert M
Pharm Unserer Zeit; 2010 May; 39(3):217-27. PubMed ID: 20425776
[No Abstract] [Full Text] [Related]
20. Epigenetics in clinical practice: the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia.
Estey EH
Leukemia; 2013 Sep; 27(9):1803-12. PubMed ID: 23757301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
